Physician profile
John Rolston
NPI 1871892091
$47,813.53
in general payments reported to CMS, 2019-2025
15 companies · $10K in 2025
The $10K reported for 2025 was more than what 86% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,307 · 2020: $873 · 2021: $6,234 · 2022: $7,394 · 2023: $708 · 2024: $13K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $4,669 · Food and Beverage: $1,831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,506.37 |
| Travel and Lodging | $4,668.87 |
| Food and Beverage | $1,831.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $18,081.89 | 2019-2025 | |
| Clearpoint Neuro, INC. | $9,014.03 | 2020-2025 | Clearpoint |
| Medtronic USA, INC. | $7,492.28 | 2019-2020 | |
| Turing Medical Technologies | $7,125.00 | 2024-2025 | |
| Medtronic, INC. | $2,290.32 | 2021-2025 | Percept PC Brainsense, Visualase |
| Insightec,INC | $1,223.69 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $742.41 | 2021 | |
| Boston Scientific Corporation | $668.30 | 2019-2024 | |
| Abbott Laboratories | $464.70 | 2019-2023 | Infinity |
| Vertex Pharmaceuticals Incorporated | $441.67 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $85.58 | 2019 | |
| Neurocrine Biosciences, INC. | $83.27 | 2019 | |
| Livanova USA, INC. | $72.72 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic Vascular, INC. | $27.67 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rolston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.